Bomet

Researchers are evaluating treatment outcomes for esophageal cancer at multiple sites within the African Esophageal Cancer Consortium (AfrECC). This prospective observational cohort study aims to describe the treatments patients receive, including chemotherapy, radiation, chemo-radiotherapy, esophageal stenting, surgery, and supportive care. It also seeks to assess patient-reported outcomes and overall survival related to these treatment approaches. Participants will receive standard treatments based on clinical decisions at participating AfrECC centers. Researchers will collect data on the types of treatments given and monitor the effects of these treatments on patients over time. Patient-reported outcomes will be gathered using questionnaires to evaluate quality of life and other relevant measures during and after treatment. Throughout the study, participants will complete questionnaires to report their outcomes, and researchers will track survival and treatment effectiveness for up to four years. The main outcomes include the proportion of patients receiving various treatments, changes in patient-reported quality of life scores, and median overall survival. This long-term follow-up will help understand the impact of current esophageal cancer treatments in the African setting.